A
0.471
-0.01 (-2.20%)
Previous Close | 0.482 |
Open | 0.495 |
Volume | 688,860 |
Avg. Volume (3M) | 6,345,736 |
Market Cap | 11,069,226 |
Price / Book | 4.90 |
52 Weeks Range | |
Earnings Date | 7 Aug 2025 - 11 Aug 2025 |
Diluted EPS (TTM) | -0.700 |
Current Ratio (MRQ) | 1.93 |
Operating Cash Flow (TTM) | -9.37 M |
Levered Free Cash Flow (TTM) | -4.87 M |
Return on Assets (TTM) | -106.68% |
Return on Equity (TTM) | -285.79% |
Market Trend
Short Term | Medium Term | ||
Industry | Biotechnology (US) | Bearish | Bearish |
Biotechnology (Global) | Bearish | Bearish | |
Stock | Acurx Pharmaceuticals, Inc. | Bearish | Bearish |
AIStockmoo Score
0.6
Analyst Consensus | 1.5 |
Insider Activity | NA |
Price Volatility | -2.0 |
Technical Moving Averages | 2.5 |
Technical Oscillators | 0.5 |
Average | 0.63 |
Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration. |
|
Sector | Healthcare |
Industry | Biotechnology |
Investment Style | Small Value |
% Held by Insiders | 10.95% |
% Held by Institutions | 17.99% |
Ownership
Name | Date | Shares Held |
---|---|---|
Prospect Financial Services Llc | 31 Mar 2025 | 366,576 |
Nbc Securities, Inc. | 31 Mar 2025 | 30,000 |
Semmax Financial Advisors Inc. | 31 Mar 2025 | 5,640 |
52 Weeks Range | ||
Median | 8.00 (1,597.07%) | |
Total | 1 Buy |
Firm | Date | Target Price | Call | Price @ Call |
---|---|---|---|---|
HC Wainwright & Co. | 15 May 2025 | 8.00 (1,597.07%) | Buy | 0.373 |
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
Realized Profit | - |
Unrealized Profit | - |
Dividend Received 2025 | - |
Total Profit | - |
Avg. Return | - |
Quantity (Buy) | - |
Avg. Price (Buy) | - |
Quantity (Sold) | - |
Avg. Price (Sold) | - |